Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform

Transfusion

Volumn 50, Issue 2, 2010, Pages 471-477

  Tormey, Christopher A ^a,b,c,d,e   Peddinghaus, Marie E ^a,b,c,d,e   Erickson, Michelle ^a,b,c,d,e   King, Karen E ^a,b,c,d,e   Cushing, Melissa M ^a,b,c,d,e   Bill, Jerry ^a,b,c,d,e   Goodrich, Tay ^a,b,c,d,e   Snyder, Edward L ^a,b,c,d,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e CaridianBCT Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; FEMALE; FLUID BALANCE; HEMOLYSIS; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BLOOD CELL COUNT; BLOOD COMPONENT REMOVAL; BLOOD PROTEINS; BLOOD VOLUME; CALCIUM GLUCONATE; CITRATES; CROSS-OVER STUDIES; EQUIPMENT DESIGN; FEMALE; GLUCOSE; GRAFT REJECTION; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PLASMA EXCHANGE; YOUNG ADULT;

EID: 75749116333     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02412.x     Document Type: Article

References (15)

1. Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL American Society for Apheresis; Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007 22 : 106 75.
2. Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1727 procedures. J Clin Apher 2007 22 : 270 6.
3. De Silvestro G, Marson P, Russo GE, Vicarioto M, Donadel C. National survey of apheresis activity in Italy (2000). Transfus Apher Sci 2004 30 : 61 71.
4. Norda R, Stegmayr BG Swedish Apheresis Group. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci 2003 29 : 159 66.
5. Crookston KP, Simon TL. Physiology of apheresis. In : McLeod BC, editor. Apheresis: principles and practices. 2nd ed. Bethesda (MD) : AABB Press 2003. p. 71 95.
6. Stefanutti C, Lanti A, Di Giacomo S, Mareri M, De Lorenzo F, Landolfo A, Isacchi G. Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks. Transfus Apher Sci 2004 31 : 3 10.
7. Weinstein R. Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange. J Clin Apher 2001 16 : 210 1.
8. Wood L, Jacobs P. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels. J Clin Apher 1986 3 : 124 8.
9. Perdue JJ, Chandler L, Vesely SK, Duvall DS, Gilcher RO, Smith JW, George JN. Unintentional PLT removal by plasmapheresis. J Clin Apher 2001 16 : 55 60.
10. Urdahl SG. COBE Spectra Apheresis System: designs, protocols and results. Infusionstherapie 1989 16 Suppl 2 : 30 43.
11. Morikawa T, Yoshida M. A useful testing strategy in phase II trials: combined test of superiority and test of equivalence. J Biopharm Stat 1995 5 : 297 306.
12. Julious SA. Sample sizes for clinical trials with normal data. Stat Med 2004 23 : 1921 86.
13. Reverberi R, Reverberi L. Removal kinetics of therapeutic apheresis. Blood Transfus 2007 5 : 164 74.
14. Burgstaler EA, Pineda AA. Therapeutic plasma exchange: a paired comparison of Fresenius AS104 vs. COBE Spectra. J Clin Apher 2001 16 : 61 6.
15. DeMott WR, Skikne BS. Hematology. In : Jacobs DS, Oxley DK, DeMott WR, editors. Jacobs and DeMott laboratory test handbook. 5th ed. Cleveland (OH) : Lexi-Comp Inc 2001. p. 446 7.